Sex: U
Vaccine: FLU4, HEPA, HPV4, MNQ, UNK
Symptoms: Product storage error
Clinical narrative: no adverse effects; Product reported as GARDASIL but lot # valid for GARDASIL 9; unspecified number of unspecified patients have been administered doses of improperly stored vaccines; This spontaneous report as received from a registered nurse, referring to a patient (gender and age not reported).  No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.  On 27-MAR-2020 at 11:23 hours, the patinet was vaccinated with an improperly stored dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) with a lot # reported as 1621931 (Reporter reported Gardasil with lot # 1621931 which was not valid for Gardasil. However, lot# 1621931 is valid for Gardasil 9) at a dose of 0.5 mL intramuscularly (IM) on the right arm (RA) and with a dose of Hepatitis A Vaccine, Inactivated (VAQTA) at a dose of 0.5 mL intramuscularly (IM) on the right arm, with a lot # reported as 747P5, and an improperly stored dose of diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid, influenza virus split virion 4v vaccine inactivated (FLUZONE) and meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA).  Administered doses of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) and Hepatitis A Vaccine, Inactivated (VAQTA) experienced the temperature excursion above 9 degrees Celsius (15.5C) for 4 hour and 6 minutes. Digital data logger was involved. There were no previous temperature excursions reported.  Lot # 747P5 is not a valid lot # for Hepatitis A Vaccine, Inactivated.    This is one of the several reports received from the same reporter.   This case comes from a case previously considered non-valid, but per new information received (patient identifiers) the case was splitted and determined to be valid for a specific patient. ; Sender's Comments:  US-009507513-2008USA008876: US-009507513-2008USA008890: US-009507513-2008USA008889: US-009507513-2003USA002275: US-009507513-2008USA008877: US-009507513-2008USA008875: US-009507513-2008USA008885: US-009507513-2008USA008880: US-009507513-2008USA008881: US-009507513-2008USA008883: US-009507513-2008USA008882: US-009507513-2008USA008879: US-009507513-2008USA008910: US-009507513-2008USA008911: US-009507513-2008USA008912: US-009507513-2008USA008913: US-009507513-2008USA008914: US-009507513-2008USA008915: US-009507513-2008USA008916: US-009507513-2008USA008917: US-009507513-2008USA008887: US-009507513-2008USA008918: US-009507513-2008USA008919: US-009507513-2008USA008890: US-009507513-2008USA008920: US-009507513-2008USA008904: US-009507513-2008USA008922: US-009507513-2008USA008923: US-009507513-2008USA008896: US-009507513-2008USA008925: US-009507513-2008USA008926: US-009507513-2008USA008927: US-009507513-2008USA008898: US-009507513-2008USA008928: US-009507513-2008USA008929: US-009507513-2008USA008899: US-009507513-2008USA008900: US-009507513-2008USA008930: US-009507513-2008USA008931: US-009507513-2008USA008909: US-009507513-2008USA008907: US-009507513-2008USA008906: US-009507513-2008USA008921: US-009507513-2008USA008903: US-009507513-2008USA008901: US-009507513-2008USA008933: